FindTrial
Sign In

DEVELOPMENT OF STANDARDISED SCREENING QUESTIONNAIRE FOR PATIENTS WITH LUMBAR SPINAL STENOSIS

LUMBAR SPINAL STENOSIS INDEX: DEVELOPMENT, VALIDATION AND RELIABILITY TESTING - LSSI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045263
Enrollment
52
Registered
2022-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M480- Spinal stenosis

Interventions

Intervention1: Test-retest reliability testing: Set of patient reported outcome measurement Intervention2: test-retest reliability: set of patient reported outcome measurement Control Intervention1: N

Sponsors

K Ramprabhu
Lead Sponsor
Dr Narkeesh Arumugam
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals of both sex between age 30-70 years presenting with pain in the low back, buttock, gluteal region or /and lower extremity, symptoms of neurogenic intermittent claudication with alleviation of symptoms in sitting/lying and aggravation of symptoms when standing and walking 2. Individuals of both sex between age 30 to 70 years diagnosed with Lumbar Spinal Stenosis having mild(grade 1), moderate (grade 2) & severe (grade 3) by Lee classification system. 3.Individuals with the ability to communicate and cooperate with the medical workers 4. Individuals who are willing to participate

Exclusion criteria

Exclusion criteria: Individuals with 1. Peripheral artery Disease(PAD) 2. Coronary artery disease(CAD) 3. Lumbar thoracic fracture 4. Lower extremity fracture 5. Scoliosis with cobs angle 6. Previous history of laminectomy 7. Any other specific spinal disorder like Ankylosing spondylitis 8. Lytic spondylolisthesis 9. Significant instability of the lumbar spine 10. Severe co morbidities

Design outcomes

Primary

MeasureTime frame
Change in the Lumbar Spinal Stenosis Index(LSSI).Timepoint: 1. The index will be administered on 2 separate occasions with similar testing conditions and the duration between the 2 test sessions shall be minimum of 24 hours and maximum of 14 days to estimate the test-retest reliability 2. Intra-rater reliability will be estimate by administering the index twice consecutively with short intervals at the convenience of the administer and the participant.—

Secondary

MeasureTime frame
NilTimepoint: Not applicable—

Countries

India

Contacts

Public ContactNarkeesh Arumugam

Punjabi University

narkeesh@gmail.com9417802662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026